Table 1

Study centres and patients in China

No. of patients
Investigator and affiliationTotal enrolledTotal randomisedRiociguat
2.5 mg-maximum dose
Riociguat
1.5 mg-maximum dose
Placebo
PATENT-18377431024
Professor Jian-Guo He (Lead investigator)
Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China
1313805
Professor Zhi-Cheng Jing
Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
23211254
Professor Da-Xin Zhou
Donghua Zhou, School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
1212525
Professor Yi-Gao Huang
Institute of Vascular Medicine, Li Ka Shing Institute of Health Sciences, School of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong
Guangdong General Hospital and Guangdong Cardiovascular Institute, Guangzhou, Guangdong, China
1613823
Professor Chen Wang
Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
Department of Beijing Hospital, Ministry of Health, Beijing, China
19181017
CHEST-158322111
Associate Professor Zhi-Hong Liu
Centre for Pulmonary Vascular Diseases, Fuwai Hospital and Cardiovascular Institute, Beijing, China
7431
Professor Chen Wang
Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, PR China
Department of Beijing Hospital, Ministry of Health, Beijing, China
3221156
Professor Zhao-Zhong Cheng
The Affiliated Hospital of Medical College of Qingdao, Shandong, China
3000
Professor Zhi-Cheng Jing
Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai, China
Thrombosis and Vascular Medicine Centre, State Key Lab of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China
14734
Professor Lei Pan
Capital Medical University, Beijing, China
2000
Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, China